Caspase-8 Expression Is Predictive of Tumour Response to Death Receptor 5 Agonist Antibody in Ewing’s Sarcoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity Against Rhabdomyosarcoma With the Expression of Caspase-8 Predictive of Response

Clinical Cancer Research
Cancer ResearchOncology
2011English

Activation of P38 Mitogen-Activated Protein Kinase Is Required for Death Receptor-Independent Caspase-8 Activation and Cell Death in Response to Sphingosine

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2009English

Ewing’s Sarcoma or Primitive Neuroectodermal Tumour of Cervix: A Case Report

Journal of Evolution of Medical and Dental sciences
2014English

Antagonism Pattern Detection Between MicroRNA and Target Expression in Ewing’s Sarcoma

PLoS ONE
Multidisciplinary
2012English

Studies in Antibody Response of Mice to Tumour Inoculation

British Journal of Cancer
Cancer ResearchOncology
1950English

Ewing’s Sarcoma of the Mobile Spine

Romanian Neurosurgery
2019English

Metastatic Ewing’s Sarcoma in Mandible: A Rarity

IOSR Journal of Dental and Medical Sciences
2017English

Structure-Function Based Molecular Relationships in Ewing’s Sarcoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Absence of Caspase 8 and High Expression of PED Protect Primitive Neural Cells From Cell Death

Journal of Experimental Medicine
MedicineAllergyImmunology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy